['schizophrenia']
['alk3831', 'olanzapine', 'placebo']

        Inclusion Criteria:

          -  Has a body mass index (BMI) of 18.0 - 40.0 kg/m^2

          -  Meets criteria for the diagnosis of schizophrenia

          -  Resides in a stable living situation when not hospitalized

          -  Is willing and able to provide government-issued identification

          -  Additional criteria may apply

        Exclusion Criteria:

          -  Has had a psychiatric hospitalization for more than 30 days during the 90 days before
             screening

          -  Subject initiated first antipsychotic treatment within the past 12 months, or <1 year
             has elapsed since the initial onset of active-phase of schizophrenia symptoms

          -  Subject poses a current suicide risk

          -  Subject has a history of treatment resistance

          -  Subject has a history of poor or inadequate response to treatment with olanzapine

          -  Subject requires or has had electroconvulsive therapy (ECT) treatment in the 2-month
             period prior to screening

          -  Subject has a diagnosis of moderate or severe alcohol or drug use disorder

          -  Subject has a positive urine drug screen for opioids, amphetamine/methamphetamine,
             phencyclidine, or cocaine at screening

          -  Additional criteria may apply
      